Publication date: December 2026 Source: Seminars in Oncology, Volume 53, Issue 6 Author(s): Christina Blagojevic, Richard B. Kim, David N. Juurlink, Jonathan S. Zipursky
Rhabdomyolysis resulting from the interaction of rosuvastatin and abiraterone: A case study. // Seminars in Oncology. – URL: https://www.sciencedirect.com/science/article/pii/S0093775426001041?dgcid=rss_sd_all
Rhabdomyolysis resulting from the interaction of rosuvastatin and abiraterone: A case study. Seminars in Oncology. https://www.sciencedirect.com/science/article/pii/S0093775426001041?dgcid=rss_sd_all
“Rhabdomyolysis resulting from the interaction of rosuvastatin and abiraterone: A case study.” Seminars in Oncology.
@article{article65819,
title = {Rhabdomyolysis resulting from the interaction of rosuvastatin and abiraterone: A case study},
journal = {Seminars in Oncology},
url = {https://www.sciencedirect.com/science/article/pii/S0093775426001041?dgcid=rss_sd_all}
}
ABSTRACT Diagnosing and classifying platelet disorders (PD) is challenging in children. Therefore, we evaluated clinical, laboratory, and genetic data to improve current algorithms by performing a prospective observational cohort study...
Abstract Background and Objectives Perioperative blood transfusion in hip arthroplasty is associated with increased morbidity, prolonged hospitalization, and higher costs. This study aimed to identify independent risk factors and...